Empowering Collaborative
Diabetes and Insulin Management
Connecting with healthcare leaders and clinicians, leveraging next-generation insights and decision support technology.
Improved Patient
Safety and Outcomes
Reduced Length of Stay
(Increased Available ICU Beds)
Rapid and Easy
Adoption
Reduced Workflow
Time and Errors
Proven 6-8x ROI
Glytec’s Industry Leading SaaS Platform
Trusted by 350+ hospitals, empowers collaborative diabetes management and insulin dosing, improving patient outcomes, reducing readmissions, and streamlining workflows while delivering a 6-8x ROI. The first-ever FDA-cleared cloud-based insulin management software is EMR-integrated, easy to set up, and validated by 127 patents and over 100 publications.
Our Results Speak for Themselves
With Glytec’s powerful suite of solutions, diabetes and insulin management doesn’t need to be hard.
See why hundreds of hospital executives and clinical providers rely on us to save time, reduce costs, promote health equity and improve patient outcomes.
$4.5M
Annual Cost Savings for a 1K Bed Hospital
Improved Financial Results
Improvement
Over Competitors
Proven ROI
AVG Cost Savings per
Severe Hypo Event
Improved Clinical Efficiency
Client Satisfaction
Per Shift Savings
Nurse Time Savings
Improved Patient Outcomes
Reduction in
Inpatient Hypoglycemia
Reduction in A1C
Reduction in 30-Days
Readmisions
We Are Trusted by Over 350+ Hospital Clients
Trusted by over 350 hospitals and clinical centers nationwide, to drive best practices in insulin management and medication optimization like other leading healthcare organizations.
We are #1 for a Reason
1st in Trust
We are the most trusted name in diabetes management with over 120 patents and 100 whitepapers.
1st to Innovate
We published the original guidelines for diabetes mangement protocols.
1st Approved Device
The first FDA-approved glucose management software for insulin titration.
1st Full Care Solution
The first to deliver a full care-continuum solution to hospital clients.
1st in Predictive Analytics
Providing predictive analytics to forecast hyper and hypoglycemic events.
1st in CMS Reporting
The first to prepare you for the 2023 CMS single eCQM reporting on hyper and hypoglycemic metrics.
1st to use AI/ML Optimization
Incorporating AI to optimize insulin dosing, analyze ordering patterns, and maximizing workflow efficiencies and treatment outcomes.
1st in Advanced High-Risk Targeting
The first to implement advanced scoring to target high-risk individuals and groups for preventative interventions.
See How We’ve Helped Our Partners Succeed
Learn how Riverside Healthcare saved more than $2.6 million annually by partnering with Glytec and implementing our solutions.
$1.0M+ Cost Savings
80% Time Saved
Don’t Take Our Word for It.
See What Customers Are Saying About Us
